RO4927350 [876755-27-0]

TargetMol Chemicals

RO4927350 [876755-27-0]

86

Research Use Only

RO4927350

C27H28N4O6S

536.6

RO4927350 is a potent and highly selective non-ATP-competitive MEK1/2 inhibitor. RO4927350 selectively blocks the MAPK pathway signaling both in vitro and in vivo, which results in significant antitumor efficacy in a broad spectrum of tumor models. RO4927350 inhibits not only ERK1/2 but also MEK1/2 phosphorylation. In cancer cells, high basal levels of phospho-MEK1/2 rather than phospho-ERK1/2 seem to correlate with greater sensitivity to RO4927350. Furthermore, RO4927350 prevents a feedback increase in MEK phosphorylation, which has been observed with other MEK inhibitors. RO4927350 represents a novel therapeutic modality in cancers with aberrant MAPK pathway activation.

3 years

[C@H]([C@@H](C)C1=CC=CC=C1)(C(NC2=NC(C(CC)=O)=CS2)=O)N3C(=O)[C@H](NC3=O)C4=CC=C(OCCO)C=C4

-20°C

12352200